ABSTRAK
Tujuan penelitian ini adalah untuk melihat perbandingan terapi,toksisitas dan kesintasanhidup. Pasien predominan usia antara 40-60 tahun (81,7%),Karsinoma sel skuamosa (78,8%),diffrensiasis sedang (63,5%), stadium III B (68,3%), dan ukuran tumor > 4 cm (62,5%)Kemoradiasi merupakan terapi yang umumnya dilakukan. Karbogen ( karbon dioksida 2%dan oksigen 98%) + Nikotinamid meningkatkan oksigenisasi tumorABSTRACT
The purpose of this study was to compare the therapies, toxicity and survival oflife. Patients are predominantly aged between 40-60 years (81.7%), squamouscell carcinoma (78.8%), diffrensiasis moderate (63.5%), stage III B (68.3%), andtumor size> 4 cm (62.5%) Chemoradiation is a therapy that is generally done.Karbogen (2% carbon dioxide and 98% oxygen) + Nicotinamide improve tumoroxygenation;The purpose of this study was to compare the therapies, toxicity and survival oflife. Patients are predominantly aged between 40-60 years (81.7%), squamouscell carcinoma (78.8%), diffrensiasis moderate (63.5%), stage III B (68.3%), andtumor size> 4 cm (62.5%) Chemoradiation is a therapy that is generally done.Karbogen (2% carbon dioxide and 98% oxygen) + Nicotinamide improve tumoroxygenation;The purpose of this study was to compare the therapies, toxicity and survival oflife. Patients are predominantly aged between 40-60 years (81.7%), squamouscell carcinoma (78.8%), diffrensiasis moderate (63.5%), stage III B (68.3%), andtumor size> 4 cm (62.5%) Chemoradiation is a therapy that is generally done.Karbogen (2% carbon dioxide and 98% oxygen) + Nicotinamide improve tumoroxygenation;The purpose of this study was to compare the therapies, toxicity and survival oflife. Patients are predominantly aged between 40-60 years (81.7%), squamouscell carcinoma (78.8%), diffrensiasis moderate (63.5%), stage III B (68.3%), andtumor size> 4 cm (62.5%) Chemoradiation is a therapy that is generally done.Karbogen (2% carbon dioxide and 98% oxygen) + Nicotinamide improve tumoroxygenation